-
Communities
-
Explore Vanderbilt communities
By latest
Featured community
Creative Data Solutions (CDS) is a Vanderbilt Shared Resource and has extensive experience in providing effective and robust solutions to challenges pertaining to research data using modern informatics and bioinformatics approaches.
-
- Resources
-
People
-
Publications
-
Explore publications
-
Type 1 and Type 2 Diabetes Drug Study
TBD
- Category
- Page
- Record History
- Added on September 25, 2017 at 10:18 AM by Kimber, Jessica
Modified on September 25, 2017 at 10:18 AM by Kimber, Jessica - Shared with (contributions)
- DRTC: Clinical Trials
Type 1 and Type 2 Diabetes Drug Study
The purpose of this study is to compare commonly used diabetes medications in relation to gylcemia-lowering effectiveness in diabetes patients.
To qualify to participate:
- Be 30 years of age or older
- Men or women diagnosed with diabetes at age ≥ 30 years (≥ 20
for American Indians)
- Duration of diagnosed diabetes < 10 years
- Willingness to administer daily subcutaneous injections, take a
second diabetes drug after randomization, potentially initiate
insulin and intensify insulin therapy if study metabolic goals are
not met, perform self-monitoring of blood glucose
- Fluent in either English or Spanish
- A negative pregnancy test for all females of childbearing potential (i.e. pre-menopausal, and not surgically sterile)
How to Participate
To participate, contact Stephanie Martin at (615) 936-1075 or e-mail at stephanie.michon@vanderbilt.edu.
